These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24080309)

  • 41. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
    Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta.
    Giorelli M; Livrea P; Trojano M
    J Interferon Cytokine Res; 2005 Jul; 25(7):395-406. PubMed ID: 16022584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
    Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
    FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
    Valenzuela RM; Costello K; Chen M; Said A; Johnson KP; Dhib-Jalbut S
    Mult Scler; 2007 Jul; 13(6):754-62. PubMed ID: 17613604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of season on cytokine expression in multiple sclerosis and healthy subjects.
    Stewart N; Taylor B; Ponsonby AL; Pittas F; van der Mei I; Woods G; Walters H
    J Neuroimmunol; 2007 Aug; 188(1-2):181-6. PubMed ID: 17628701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
    Pampliega O; Domercq M; Villoslada P; Sepulcre J; Rodríguez-Antigüedad A; Matute C
    J Neuroimmunol; 2008 Mar; 195(1-2):194-8. PubMed ID: 18378006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
    J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
    Weinstock-Guttman B; Zivadinov R; Tamaño-Blanco M; Abdelrahman N; Badgett D; Durfee J; Hussein S; Feichter J; Patrick K; Benedict R; Ramanathan M
    J Neuroimmunol; 2007 Aug; 188(1-2):167-74. PubMed ID: 17602759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin D and IFN-β Modulate the Inflammatory Gene Expression Program of Primary Human T Lymphocytes.
    Bianchi N; Emming S; Zecca C; Monticelli S
    Front Immunol; 2020; 11():566781. PubMed ID: 33343562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis.
    Frisullo G; Mirabella M; Angelucci F; Caggiula M; Morosetti R; Sancricca C; Patanella AK; Nociti V; Iorio R; Bianco A; Tomassini V; Pozzilli C; Tonali PA; Matarese G; Batocchi AP
    J Neuroimmunol; 2007 Dec; 192(1-2):174-83. PubMed ID: 17904647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced levels of Coco in sera of multiple sclerosis patients: A potential role in neuro-regeneration failure.
    Mausner-Fainberg K; Penn M; Golan M; Benhamou M; Wilf-Yarkoni A; Gertel S; Karni A
    J Neuroimmunol; 2019 Feb; 327():36-40. PubMed ID: 30685069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
    Navone ND; Perga S; Martire S; Berchialla P; Malucchi S; Bertolotto A
    J Neuroimmunol; 2014 Jul; 272(1-2):99-102. PubMed ID: 24852325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis.
    Tynyakov-Samra E; Auriel E; Levy-Amir Y; Karni A
    Mult Scler Int; 2011; 2011():561262. PubMed ID: 22096639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations of the human gut microbiome in multiple sclerosis.
    Jangi S; Gandhi R; Cox LM; Li N; von Glehn F; Yan R; Patel B; Mazzola MA; Liu S; Glanz BL; Cook S; Tankou S; Stuart F; Melo K; Nejad P; Smith K; Topçuolu BD; Holden J; Kivisäkk P; Chitnis T; De Jager PL; Quintana FJ; Gerber GK; Bry L; Weiner HL
    Nat Commun; 2016 Jun; 7():12015. PubMed ID: 27352007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis.
    Sharief MK; Semra YK
    J Neuroimmunol; 2001 Oct; 119(2):358-64. PubMed ID: 11585640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.